Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

Quantum Biopharma Reports Positive Phase 1 Safety For Multiple Sclerosis Drug

Quantum Biopharma Ltd. (NASDAQ:QNTM) announced on Tuesday that its subsidiary Huge Biopharma Australia has received the clinical study report for a Phase 1, randomized, double-blind, placebo-controlled multiple ascending dose trial evaluating the safety and pharmacokinetics of Lucid-MS in healthy adults.

Benzinga

Weakness In Vertex Stock Seen As Buying Opportunity

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) stock is falling on Tuesday after the company’s pain data overshadowed strong second-quarter earnings.

Benzinga

Inspire Medical Plunges On Outlook Cut, Weak V System Rollout: Analysts React

Inspire Medical Systems, Inc. (NYSE:INSP) stock is plunging after the company released its second-quarter earnings and cut its annual guidance.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Alcon Expands Vision Correction Portfolio With STAAR Surgical Acquisition

On Tuesday, the eye care company Alcon Plc (NYSE:ALC) agreed to acquire STAAR Surgical Company (NASDAQ:STAA), the manufacturer of the implantable collamer lens (ICL).

Benzinga

I’m a perinatal psychiatrist. The US is promoting misinformation on SSRIs and pregnancy

A recent FDA advisory panel discussion contained falsehoods and overstated risks. That’s dangerous for mothers-to-be

The Guardian - US

Viatris Stock: Analyst Estimates & Ratings

Viatris has considerably underperformed the broader market over the past year, and analysts are cautious about the stock’s prospects.

Barchart

Novo Nordisk Stock Sinks—But Is a Bottom Finally In?

Novo Nordisk stock is down over 43% in 2025 as investors weigh weak guidance, GLP-1 competition, and the potential for a rebound after earnings

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Covid cases rising in US as officials plan to restrict booster vaccines

Risks of a wave are compounded by new vaccine restrictions from the Trump administration

The Guardian - US

FDA Sounds Alarm On Nationwide Butter Recall: Upgrades Risk Over Allergen Warning

The Food and Drug Administration has heightened concerns over a nationwide butter recall, escalating the risk level after discovering the presence of an undeclared major allergen.

Benzinga

5 Products That Vanished From Stores Without a Recall Notice

When a product is recalled, there is an official announcement from the manufacturer and a government agency like the CPSC or the FDA. However, sometimes a product disappears from store shelves suddenly and quietly, with no recall notice to explain its absence. This “silent discontinuation” often happens when a product…

Grocery Coupon Guide

Why Is Replimune Stock Trading Lower On Monday?

On Monday, Replimune Group Inc. (NASDAQ:REPL) is reeling after the FDA unexpectedly rejected its skin cancer treatment, triggering a stock plunge and a wave of investor outrage.

Benzinga

8 Cleaning Products That Lost Their FDA Approval But Are Still on Shelves

Keeping your home clean is important. You want to trust the cleaning products you buy. But what if some of those products lost their FDA approval and are still on store shelves? This isn’t just about following rules. It’s about your health and safety. Some products may not work as…

Grocery Coupon Guide

FDA Butter Recall Hits Second-Highest Warning Over 'Harmless' Ingredient That Could Be Dangerous

Bunge's butter recall hits Class II warning after milk allergen left off label, spotlighting FDA oversight and labelling requirements.

International Business Times UK

10 Discontinued Medications Still Sitting in Bathroom Cabinets

Open almost any bathroom cabinet in America, and you’re likely to find a few bottles of forgotten pills. Maybe they were prescribed years ago for...

Saving Advice

Get all your
news in one place.

100's of premium titles.
One news app.

Grocery Coupon Guide

7 Foods That Became Trendy—Then Got Banned

Trendy foods come and go, but some leave a bigger mark than others. Sometimes, a food gets so popular that it’s everywhere—until it suddenly disappears. Why? Because some trendy foods end up getting banned. This can happen for health reasons, environmental concerns, or even legal issues. If you care about…

Grocery Coupon Guide

8 Things That Were “Banned” But Quietly Returned to Shelves

When a product gets banned, it often makes headlines. Whether it’s due to health concerns, political controversy, or public backlash, banned items tend to stir up emotions—and disappear overnight. But not all bans last forever. Over time, some items are quietly reformulated, relabeled, or simply reintroduced with little fanfare. Here…

The Independent UK

Freeze-dried fruit sold in 42 states recalled over Listeria fears

The recalled fruit was sold at Sam’s Club stores in 42 states

Benzinga

Novo Nordisk's Alhemo Wins FDA Nod, Expanding Subcutaneous Option For Hemophilia Patients

The U.S. Food and Drug Administration approved on Friday, the Novo Nordisk A/S (NYSE:NVO) Alhemo (concizumab-mtci) injection as a once-daily prophylaxis to prevent or reduce the frequency of bleeding episodes in patients 12 years of age and older with hemophilia A or B without inhibitors.

Get all your
news in one place.

100's of premium titles.
One news app.

We Got This Covered

Laura Loomer just admitted she’s running a ‘tip line’ to get Trump officials fired and predicts ‘hundreds’ more pink slips

Loomer's purge machine.

Benzinga

LENZ Therapeutics' Eye Drop Scores First FDA Approval For Age-Related Blurred Vision Condition Impacting 128 Million People

On Thursday, the U.S. Food and Drug Administration approved LENZ Therapeutics, Inc.’s (NASDAQ:LENZ) VIZZ (aceclidine ophthalmic solution, previously known as LNZ100) 1.44%, the first and only FDA-approved aceclidine-based eye drop for presbyopia in adults.

Benzinga

Regeneron's Pipeline Hit By Catalent Delays, But Dupixent Shines

On Friday, Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) reported second-quarter adjusted earnings of $12.89 per share, up 12% year-over-year, beating the consensus of $8.57.

Benzinga

Moderna's Key Patent Win Overshadowed By Gloomy Outlook

Moderna Inc. (NASDAQ:MRNA) reported on Friday a second-quarter loss of $2.13 per share, beating the consensus of a $2.98 loss, an improvement from a loss of $3.33 a year ago.

Barchart

Should You Buy the Post-Earnings Plunge in Novo Nordisk Stock or Stay Far, Far Away?

Novo Nordisk is a healthcare stock that is down 50% in 2025. Is NVO stock undervalued at current levels or can it move lower over the next 12 months?

International Business Times UK

Lyme Disease Explained: Hidden Symptoms, and Why Justin Timberlake Is Sounding the Alarm

Justin Timberlake's health battle highlights the hidden symptoms of Lyme disease amid a sharp rise in 2025 US cases

Grocery Coupon Guide

10 Food Packaging Lies That Make You Overeat

Food manufacturers are masters of psychology, using clever language and design on their packaging to make products seem healthier than they are. This marketing technique, known as creating a “health halo,” tricks our brains into giving a food item a pass. We feel less guilty about consuming it, which often…

1 … 34 35 36 37

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.